Guidelines
for Consideration of ECMO
|
Reviewed by John Beca (PICU) and Carl Kuschel |
| July 2002 |
| Eligibility Criteria | Contraindications | Pre-ECMO Investigations |
| Optimal Pre-ECMO Tubes and Lines | Consideration of ECMO |
ECMO is proven treatment for life-threatening respiratory and/or cardiac failure in neonates. Overall survival rates are approximately 80% in infants with a predicted survival of 20%.
ANY of the following AND underlying disease process which is likely to be reversible
| 1. | OI ≥30 - 60 for 0.5 - 6 hours | OI =
(MAP x FiO2 x 100) / PaO2 (mmHg) (click
here to open the OI calculator) Standard criteria: OI ≥40 on conventional ventilation OI ≥50-60 for HFOV |
| 2. | PaO2 <5.3kPa (40mmHg) for >2 hours | Despite maximal ventilatory support |
| 3. | Acidosis and Shock | pH
<7.25 due to metabolic acidosis Raised lactate Intractable hypotension |
Absolute
Lethal malformations or congenital anomalies
Relative
| Investigation | Responsibility |
| CXR | NICU |
| FBC and Differential | NICU |
| INR, APPT, Fibrinogen | NICU |
| Electrolytes Urea and Creatinine LFTs |
NICU |
| Head Ultrasound Scan | NICU |
| Cardiac Echo | NICU but should have repeat study performed by Paediatric Cardiologist prior to cannulation |
| Crossmatch (2 adult units) | NICU |
| Item | Responsibility | Comments |
| Nasal ETT | NICU |
|
| Peripheral arterial line | NICU |
|
| Double lumen femoral venous catheter | PICU | |
| Urinary catheter | NICU |
With the advent of HFOV and nitric oxide, patients being referred for ECMO will generally be sicker than previously with little or no reserve. As a treatment with a proven survival benefit, ECMO should be considered for any neonate with severe cardio-respiratory failure and discussed early to facilitate timely transfers.
As many as possible of the pre-ECMO investigations, tubes and lines should be done prior to transfer to allow for rapid initiation of ECMO if it is required.
Consider and discuss ECMO in any near-term neonate with:
If a decision is made to transfer to PICU: